Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-10 Guided Antibiotic Selection for MRSaB
NCT02660346Phase 4Completed
- Sponsor
- Sharp HealthCare
- Start
- Nov 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftaroline fosamil in Staphylococcus aureus bacteremia (SAB), sponsored by Sharp HealthCare. Started Nov 2015; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
Staphylococcus aureus bacteremia (SAB)
Beyond the preview
Go deeper on NCT02660346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660346.